SCHEMBL15480451

SCHEMBL15480451

CCCCCC(=O)N(O)C(=O)CCCCCC(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.71
PPARG P37231 7/20 0.71
PPARD Q03181 7/20 0.71
PPARA Q07869 7/20 0.71
HDAC11 Q96DB2 5/20 0.71
TSHR P16473 4/20 0.71
PTPN1 P18031 3/20 0.71
ALDH1A1 P00352 2/20 0.71
TLR2 O60603 2/20 0.71
TDP1 Q9NUW8 2/20 0.71
FABP4 P15090 2/20 0.71
KMT2A Q03164 2/20 0.71
FFAR1 O14842 2/20 0.71
FFAR4 Q5NUL3 2/20 0.71
SLC22A6 Q4U2R8 1/20 0.71
SLC22A8 Q8TCC7 1/20 0.71
MEN1 O00255 1/20 0.71
ESR1 P03372 1/20 0.71
ALOX15 P16050 1/20 0.71
PDE4A P27815 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31746124 0.91 CES2 (0.56) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL23054862 0.89 TSHR (0.63) GPR84PPARGPPARDPPARAHDAC11
Dodecanoate SCHEMBL8388298 0.84 GPR84 (0.90) GPR84PPARGPPARDPPARAHDAC11
Palmitic Acid SCHEMBL25291231 0.84 GPR84 (1.00) GPR84PPARGPPARDPPARAHDAC11
Myristic Acid SCHEMBL23705769 0.84 GPR84 (1.00) GPR84PPARGPPARDPPARAHDAC11
Behenic Acid SCHEMBL25281884 0.84 GPR84 (1.00) GPR84PPARGPPARDPPARAHDAC11
Dodecanoate SCHEMBL25293218 0.84 GPR84 (1.00) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL25295592 0.84 GPR84 (1.00) GPR84PPARGPPARDPPARAHDAC11
Hexacosanoic Acid SCHEMBL25287701 0.84 GPR84 (1.00) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL25291604 0.84 GPR84 (1.00) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170020874-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS CERENO SCIENT AB (SE) 2017-01-26 US disclosed
US-20140051716-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS CERENO SCIENTIFIC AB 2014-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051716-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS HDAC3, HDAC1, HDAC2 GPR84 4425/4885PPARG 434/4885PPARD 643/4885
US-20170020874-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS HDAC3, HDAC1, HDAC2 GPR84 4425/4885PPARG 434/4885PPARD 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.